Literature DB >> 32510182

Discovery of TBC1D7 as a Potential Driver for Melanoma Cell Invasion.

Tianyu F Qi1, Lei Guo1, Ming Huang1, Lin Li1, Weili Miao2, Yinsheng Wang1,2.   

Abstract

Metastasis is the leading cause for mortality in melanoma patients. Here, an unbiased mass spectrometry-based quantitative proteomic method is utilized to assess differential protein expression in a matched pair of primary/metastatic melanoma cell lines (i.e., WM-115/WM-266-4) derived from the same patient. It is found that TBC1D7 is overexpressed in metastatic over primary melanoma cells, and elevated expression of TBC1D7 promotes the invasion of these melanoma cells in vitro, partly through modulating the activities of secreted matrix metalloproteinases 2 and 9. Additionally, interrogation of publicly available data show that higher mRNA expression of TBC1D7 predicts poorer survival in melanoma patients. Together, the results suggest TBC1D7 as a driver for melanoma cell invasion, which is an important element in melanoma metastasis. The proteomic data generated from this study may also be useful for exploring the roles of other proteins in melanoma metastasis.
© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  SILAC; TBC domain-containing proteins; TBC1D7; mass spectrometry; melanoma metastasis; quantitative proteomics

Mesh:

Substances:

Year:  2020        PMID: 32510182      PMCID: PMC9362880          DOI: 10.1002/pmic.201900347

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   5.393


  15 in total

1.  Targeted Quantitative Profiling of GTP-Binding Proteins in Cancer Cells Using Isotope-Coded GTP Probes.

Authors:  Rong Cai; Ming Huang; Yinsheng Wang
Journal:  Anal Chem       Date:  2018-11-28       Impact factor: 6.986

2.  Targeted Quantitative Proteomic Approach for Probing Altered Protein Expression of Small GTPases Associated with Colorectal Cancer Metastasis.

Authors:  Ming Huang; Yinsheng Wang
Journal:  Anal Chem       Date:  2019-04-12       Impact factor: 6.986

3.  Degradation of endothelial basement membrane by human breast cancer cell lines.

Authors:  C Yee; R P Shiu
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

4.  A Targeted Quantitative Proteomic Approach Assesses the Reprogramming of Small GTPases during Melanoma Metastasis.

Authors:  Ming Huang; Tianyu F Qi; Lin Li; Gao Zhang; Yinsheng Wang
Journal:  Cancer Res       Date:  2018-08-02       Impact factor: 12.701

Review 5.  AKT/PKB Signaling: Navigating the Network.

Authors:  Brendan D Manning; Alex Toker
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

6.  The tuberous sclerosis complex subunit TBC1D7 is stabilized by Akt phosphorylation-mediated 14-3-3 binding.

Authors:  James P Madigan; Feng Hou; Linlei Ye; Jicheng Hu; Aiping Dong; Wolfram Tempel; Marielle E Yohe; Paul A Randazzo; Lisa M Miller Jenkins; Michael M Gottesman; Yufeng Tong
Journal:  J Biol Chem       Date:  2018-08-24       Impact factor: 5.157

7.  AKT1 Activation Promotes Development of Melanoma Metastases.

Authors:  Joseph H Cho; James P Robinson; Rowan A Arave; William J Burnett; David A Kircher; Guo Chen; Michael A Davies; Allie H Grossmann; Matthew W VanBrocklin; Martin McMahon; Sheri L Holmen
Journal:  Cell Rep       Date:  2015-10-22       Impact factor: 9.423

8.  Both decreased and increased SRPK1 levels promote cancer by interfering with PHLPP-mediated dephosphorylation of Akt.

Authors:  Pingping Wang; Zhihong Zhou; Anchang Hu; Claudio Ponte de Albuquerque; Yu Zhou; Lixin Hong; Emma Sierecki; Masahiko Ajiro; Michael Kruhlak; Curtis Harris; Kun-Liang Guan; Zhi-Ming Zheng; Alexandra C Newton; Peiqing Sun; Huilin Zhou; Xiang-Dong Fu
Journal:  Mol Cell       Date:  2014-04-03       Impact factor: 17.970

9.  TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1.

Authors:  Christian C Dibble; Winfried Elis; Suchithra Menon; Wei Qin; Justin Klekota; John M Asara; Peter M Finan; David J Kwiatkowski; Leon O Murphy; Brendan D Manning
Journal:  Mol Cell       Date:  2012-07-12       Impact factor: 17.970

10.  Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR.

Authors:  Miguel Vizoso; Humberto J Ferreira; Paula Lopez-Serra; F Javier Carmona; Anna Martínez-Cardús; Maria Romina Girotti; Alberto Villanueva; Sonia Guil; Catia Moutinho; Julia Liz; Anna Portela; Holger Heyn; Sebastian Moran; August Vidal; Maria Martinez-Iniesta; Jose L Manzano; Maria Teresa Fernandez-Figueras; Elena Elez; Eva Muñoz-Couselo; Rafael Botella-Estrada; Alfonso Berrocal; Fredrik Pontén; Joost van den Oord; William M Gallagher; Dennie T Frederick; Keith T Flaherty; Ultan McDermott; Paul Lorigan; Richard Marais; Manel Esteller
Journal:  Nat Med       Date:  2015-06-01       Impact factor: 53.440

View more
  3 in total

1.  The Spatial Landscape of Progression and Immunoediting in Primary Melanoma at Single-Cell Resolution.

Authors:  Ajit J Nirmal; Zoltan Maliga; Tuulia Vallius; Sandro Santagata; Peter K Sorger; Brian Quattrochi; Alyce A Chen; Connor A Jacobson; Roxanne J Pelletier; Clarence Yapp; Raquel Arias-Camison; Yu-An Chen; Christine G Lian; George F Murphy
Journal:  Cancer Discov       Date:  2022-06-02       Impact factor: 38.272

2.  TBC1D2 Promotes Ovarian Cancer Metastasis via Inducing E-Cadherin Degradation.

Authors:  Jiming Tian; Xiaolei Liang; Dalin Wang; Jinglin Tian; Haiping Liang; Ting Lei; Zeyu Yan; Dan Wu; Xiaoli Liu; Shujuan Liu; Yongxiu Yang
Journal:  Front Oncol       Date:  2022-04-27       Impact factor: 5.738

3.  Tre2-Bub2-Cdc16 Family Proteins Based Nomogram Serve as a Promising Prognosis Predicting Model for Melanoma.

Authors:  Ling Tang; Cong Peng; Su-Si Zhu; Zhe Zhou; Han Liu; Quan Cheng; Xiang Chen; Xiao-Ping Chen
Journal:  Front Oncol       Date:  2020-10-28       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.